245 related articles for article (PubMed ID: 10069644)
1. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients.
Soejima A; Matsuzawa N; Miyake N; Karube M; Fukuoka K; Nakabayashi K; Kitamoto K; Nagasawa T
Clin Nephrol; 1999 Feb; 51(2):92-7. PubMed ID: 10069644
[TBL] [Abstract][Full Text] [Related]
2. [Studies on the relationship between serum albumin concentration and lipid peroxidation in the erythrocyte membrane of maintenance hemodialysis patients].
Matsuzawa N
Nihon Jinzo Gakkai Shi; 2001; 43(2):55-62. PubMed ID: 11280211
[TBL] [Abstract][Full Text] [Related]
3. Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients.
Soejima A; Kaneda F; Manno S; Matsuzawa N; Kouji H; Nagasawa T; Era S; Takakuwa Y
Am J Kidney Dis; 2002 May; 39(5):1040-6. PubMed ID: 11979348
[TBL] [Abstract][Full Text] [Related]
4. Oxidative stress and erythrocyte integrity in end-stage renal failure patients hemodialysed using a vitamin E-modified membrane.
Westhuyzen J; Saltissi D; Stanbury V
Ann Clin Lab Sci; 2003; 33(1):3-10. PubMed ID: 12661892
[TBL] [Abstract][Full Text] [Related]
5. [Membrane phospholipid peroxidation in renal insufficiency and chronic hemodialysis].
Paul JL; Man NK; Moatti N; Raichvarg D
Nephrologie; 1991; 12(1):4-7. PubMed ID: 2034320
[TBL] [Abstract][Full Text] [Related]
6. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients.
Giardini O; Taccone-Gallucci M; Lubrano R; Ricciardi-Tenore G; Bandino D; Silvi I; Paradisi C; Mannarino O; Citti G; Elli M
Clin Nephrol; 1984 Mar; 21(3):174-7. PubMed ID: 6705279
[TBL] [Abstract][Full Text] [Related]
7. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure.
Mohora M; Mircescu G; Cîrjan C; Mihăilescu I; Gîrneaţă L; Ursea N; Dinu V
Rom J Intern Med; 1995; 33(3-4):237-42. PubMed ID: 8646196
[TBL] [Abstract][Full Text] [Related]
8. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell membrane lipid peroxidation and chronic haemolysis in haemodialysis patients.
Taccone-Gallucci M; Lubrano R; Mazzarella V; Bandino D; Meloni C; Morosetti M; Elli M; Giardini O; Boffo V; Tozzo C
Life Support Syst; 1985; 3 Suppl 1():41-4. PubMed ID: 3870599
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell lipid peroxidation in predialysis chronic renal failure.
Taccone-Gallucci M; Giardini O; Lubrano R; Bandino D; Mazzarella V; Mannarino O; Meloni C; Morosetti M; Elli M; Tozzo C
Clin Nephrol; 1987 May; 27(5):238-41. PubMed ID: 3594939
[TBL] [Abstract][Full Text] [Related]
11. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure].
Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa
Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935
[TBL] [Abstract][Full Text] [Related]
12. [Lipid peroxidation as a possible mechanism of erythrocyte damage in patients with chronic kidney failure on hemodialysis].
Balashova TS; Rud'ko IA; Ermolenko VM; Tsalenchuk IaP; Kubatiev AA
Ter Arkh; 1992; 64(6):66-9. PubMed ID: 1440343
[TBL] [Abstract][Full Text] [Related]
13. Whole blood-, plasma- and red blood cell glutathione and cysteine in patients with kidney disease and during hemodialysis.
Jacobson SH; Moldéus P
Clin Nephrol; 1994 Sep; 42(3):189-92. PubMed ID: 7994938
[TBL] [Abstract][Full Text] [Related]
14. [The morphofunctional damage to the biomembranes in the lipid peroxidation syndrome in patients with the terminal stage of chronic kidney failure].
Grinshteĭn IuI; Linev KA
Urol Nefrol (Mosk); 1989; (6):45-8. PubMed ID: 2617738
[TBL] [Abstract][Full Text] [Related]
15. Increased erythrocyte susceptibility to lipid peroxidation in myeloproliferative disorders.
Gilbert HS; Roth EF; Ginsberg H
J Lab Clin Med; 1984 Jan; 103(1):6-13. PubMed ID: 6690640
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
18. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell susceptibility to lipid peroxidation, membrane lipid composition and antioxidant enzymes in patients with rheumatoid arthritis.
Olivieri O; Girelli D; Trevisan MT; Bassi A; Zorzan P; Bambara LM; Corrocher R
J Rheumatol; 1991 Aug; 18(8):1263-4. PubMed ID: 1941839
[No Abstract] [Full Text] [Related]
20. Administration of GSH has no influence on the RBC membrane: oxidative damage to patients on hemodialysis.
Taccone-Gallucci M; Lubrano R; Clerico A; Meloni C; Morosetti M; Meschini L; Elli M; Trapasso E; Castello MA; Casciani CU
ASAIO J; 1992; 38(4):855-7. PubMed ID: 1450486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
